Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds - Publication - Bridge of Knowledge

Your account

login

Search

Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds

Abstract

Objective: This study evaluated the use of novel peptides derived from platelet-derived growth factor (PDGF-BB) as potential wound healing stimulants. One of the compounds (named PDGF2) was subjected for further research after cytotoxicity and proliferation assays on human skin cells. Further investigation included evaluation of: migration and chemotaxis of skin cells, immunological and allergic safety, the transcriptional analyses of adipose-derived stem cells (ASCs) and dermal fibroblasts stimulated with PDGF2, and the use of dorsal skin wound injury model to evaluate the effect of wound healing in mice. Approach: Colorimetric lactate dehydrogenase and tetrazolium assays were used to evaluate the cytotoxicity and the effect on proliferation. PDGF2 effect on migration and chemotaxis was also checked. Immunological safety and allergic potential were evaluated with a lymphocyte activation and basophil activation test. Transcriptional profiles of ASCs and primary fibroblasts were assessed after stimulation with PDGF2. Eight-week-old BALB/c female mice were used for dorsal skin wound injury model. Results: PDGF2 showed low cytotoxicity, pro-proliferative effects on human skin cells, high immunological safety, and accelerated wound healing in mouse model. Furthermore, transcriptomic analysis of ASCs and fibroblasts revealed the activation of processes involved in wound healing and indicated its safety. Innovation: A novel peptide derived from PDGF-BB was proved to be safe drug candidate in wound healing. We also present a multifaceted in vitro model for the initial screening of new compounds that may be potentially useful in wound healing stimulation. Conclusion: The results show that peptide derived from PDGF-BB is a promising drug candidate for wound treatment.

Citations

  • 2 6

    CrossRef

  • 0

    Web of Science

  • 2 8

    Scopus

Authors (24)

Cite as

Full text

full text is not available in portal

Keywords

Details

Category:
Articles
Type:
artykuły w czasopismach
Published in:
Advances in Wound Care no. 9, pages 657 - 675,
ISSN: 2162-1918
Language:
English
Publication year:
2020
Bibliographic description:
Deptuła M., Karpowicz P., Wardowska A., Sass P., Sosnowski P., Mieczkowska A., Filipowicz N., Dzierżyńska M., Sawicka J., Nowicka E., Langa P., Schumacher A., Cichorek M., Zieliński J., Kondej K., Kasprzykowski F., Czupryn A., Janus Ł., Mucha P., Skowron P., Piotrowski A., Sachadyn P., Rodziewicz-Motowidło S., Pikuła M.: Development of a Peptide Derived from Platelet-Derived Growth Factor (PDGF-BB) into a Potential Drug Candidate for the Treatment of Wounds// Advances in Wound Care -Vol. 9,iss. 12 (2020), s.657-675
DOI:
Digital Object Identifier (open in new tab) 10.1089/wound.2019.1051
Verified by:
Gdańsk University of Technology

seen 171 times

Recommended for you

Development and evaluation of RADA-PDGF2 self-assembling peptide hydrogel for enhanced skin wound healing

  • M. Deptula,
  • J. Sawicka,
  • P. Sass
  • + 14 authors
2023

Imunofan—RDKVYR Peptide—Stimulates Skin Cell Proliferation and Promotes Tissue Repair

  • J. Sawicka,
  • M. Dzierżyńska,
  • A. Wardowska
  • + 26 authors
2020

Release systems based on self-assembling RADA16-I hydrogels with a signal sequence which improves wound healing processes

  • M. Dzierżyńska,
  • J. Sawicka,
  • M. Deptula
  • + 11 authors
2023

Imunofan - RDKVYR peptide - stimulates skin cell proliferation and promotes tissue repair

2020
Meta Tags